Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 2/20 | 0.55 |
| ▸ | ERAP2 | Q6P179 | 5/20 | 0.53 |
| ▸ | ERAP1 | Q9NZ08 | 4/20 | 0.53 |
| ▸ | LNPEP | Q9UIQ6 | 4/20 | 0.53 |
| ▸ | NPY1R | P25929 | 2/20 | 0.52 |
| ▸ | NPY2R | P49146 | 2/20 | 0.52 |
| ▸ | NPY4R | P50391 | 2/20 | 0.52 |
| ▸ | ECE1 | P42892 | 3/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29924961 | 1.00 | ACE (0.55) | ACEERAP2ERAP1LNPEPNPY1R | |
| SCHEMBL29662004 | 1.00 | ACE (0.55) | ACEERAP2ERAP1LNPEPNPY1R | |
| SCHEMBL30389391 | 0.99 | ACE (0.54) | ACEERAP2ERAP1LNPEPNPY1R | |
| SCHEMBL30462544 | 0.99 | ACE (0.54) | ACEERAP2ERAP1LNPEPNPY1R | |
| SCHEMBL30389486 | 0.99 | ACE (0.54) | ACEERAP2ERAP1LNPEPNPY1R | |
| SCHEMBL30389400 | 0.99 | ACE (0.54) | ACEERAP2ERAP1LNPEPNPY1R | |
| SCHEMBL29837379 | 0.99 | ACE (0.54) | ACEERAP2ERAP1LNPEPNPY1R | |
| SCHEMBL30646171 | 0.99 | ACE (0.54) | ACEERAP2ERAP1LNPEPNPY1R | |
| SCHEMBL30945412 | 0.99 | ACE (0.54) | ACEERAP2ERAP1LNPEPNPY1R | |
| SCHEMBL30388732 | 0.99 | ACE (0.54) | ACEERAP2ERAP1LNPEPNPY1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220289794-A1 | SYNTHETIC ANTIMICROBIAL PEPTIDES | AJK BIOPHARMACEUTICAL LLC (US) | 2022-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220289794-A1 | SYNTHETIC ANTIMICROBIAL PEPTIDES | VIP, HM13, NGLY1 | ACE 2034/4885ERAP2 506/4885ERAP1 208/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.